Vir Biotechnology Stock Options
| VIR Stock | USD 11.20 0.67 6.36% |
Vir Biotechnology's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.38 with a put-to-call open interest ratio of 0.47 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 13.0.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Vir Biotechnology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Vir Biotechnology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Vir Biotechnology's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Vir Biotechnology
Analyzing Vir Biotechnology's in-the-money options over time can help investors to take a profitable long position in Vir Biotechnology regardless of its overall volatility. This is especially true when Vir Biotechnology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Vir Biotechnology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Vir Biotechnology's stock while costing only a fraction of its price.
Vir Biotechnology In The Money Call Balance
When Vir Biotechnology's strike price is surpassing the current stock price, the option contract against Vir Biotechnology stock is said to be in the money. When it comes to buying Vir Biotechnology's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Vir Biotechnology are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Vir Current Options Market Mood
Vir Biotechnology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Vir Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Vir Biotechnology's options investors are not very successful. Vir Biotechnology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Vir contract
Base on the Rule 16, the options market is currently suggesting that Vir Biotechnology will have an average daily up or down price movement of about 0.0862% per day over the life of the 2025-04-17 option contract. With Vir Biotechnology trading at USD 11.2, that is roughly USD 0.00966. If you think that the market is fully incorporating Vir Biotechnology's daily price movement you should consider buying Vir Biotechnology options at the current volatility level of 1.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Vir |
Purchasing Vir Biotechnology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Vir calls. Remember, the seller must deliver Vir Biotechnology stock to the call owner when a call is exercised.
Vir Biotechnology Option Chain
When Vir Biotechnology's strike price is surpassing the current stock price, the option contract against Vir Biotechnology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Vir Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Vir. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vir. It also shows strike prices and maturity days for a Vir Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | VIR250417C00002500 | 1 | 2.5 | 6.6 - 9.0 | 7.33 | In |
Call | VIR250417C00005000 | 17 | 5.0 | 4.3 - 6.2 | 7.8 | In |
Call | VIR250417C00007500 | 21 | 7.5 | 2.65 - 4.2 | 6.34 | In |
Call | VIR250417C00010000 | 818 | 10.0 | 1.25 - 2.15 | 1.35 | In |
Call | VIR250417C00012500 | 107 | 12.5 | 0.0 - 1.6 | 0.7 | Out |
Call | VIR250417C00015000 | 205 | 15.0 | 0.15 - 0.9 | 0.3 | Out |
Call | VIR250417C00017500 | 0 | 17.5 | 0.0 - 0.4 | 0.4 | |
Call | VIR250417C00020000 | 0 | 20.0 | 0.0 - 0.6 | 0.6 | |
Call | VIR250417C00022500 | 0 | 22.5 | 0.0 - 0.5 | 0.5 | |
Call | VIR250417C00025000 | 0 | 25.0 | 0.0 - 0.75 | 0.75 | |
Put | VIR250417P00002500 | 0 | 2.5 | 0.0 - 2.75 | 2.75 | |
Put | VIR250417P00005000 | 102 | 5.0 | 0.0 - 0.75 | 0.75 | Out |
Put | VIR250417P00007500 | 128 | 7.5 | 0.0 - 0.45 | 0.3 | Out |
Put | VIR250417P00010000 | 127 | 10.0 | 0.8 - 1.2 | 1.15 | Out |
Put | VIR250417P00012500 | 85 | 12.5 | 2.05 - 3.2 | 2.5 | In |
Put | VIR250417P00015000 | 112 | 15.0 | 4.4 - 5.0 | 4.94 | In |
Put | VIR250417P00017500 | 0 | 17.5 | 5.4 - 7.8 | 5.4 | In |
Put | VIR250417P00020000 | 0 | 20.0 | 8.0 - 10.4 | 8.0 | In |
Put | VIR250417P00022500 | 0 | 22.5 | 10.1 - 12.9 | 10.1 | In |
Put | VIR250417P00025000 | 0 | 25.0 | 13.3 - 15.9 | 13.3 | In |
Vir Biotechnology Market Cap Over Time
Market Cap |
| Timeline |
Vir Total Stockholder Equity
Total Stockholder Equity |
|
Vir Biotechnology Corporate Management
| Vanina JD | General VP | Profile | |
| Klaus Frueh | CoFounder Advisor | Profile | |
| Lawrence MD | CoFounder Advisor | Profile | |
| Johanna FriedlNaderer | Ex COO | Profile | |
| George Scangos | CEO Pres | Profile | |
| Louis MD | CoFounder Advisor | Profile |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.